| Human |
hsa_circ_SMARCA5 |
- |
SMARCA5 / chr4:144464662-144465125 |
colorectal cancer |
SMARCA5 |
- |
Q
S
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
circSMARCA5 |
glioblastoma |
SMARCA5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
circSMARCA5 |
hepatocellular carcinoma |
SMARCA5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
- |
glioblastoma |
SMARCA5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
- |
gastric cancer |
SMARCA5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
Chr4:144464662|144465125 |
hepatocellular carcinoma |
SMARCA5 |
- |
S
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
- |
non-small cell lung carcinoma |
SMARCA5 |
miR-19b-3p |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
- |
intrahepatic cholangiocarcinoma |
SMARCA5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
cSMARCA5 |
cervical cancer |
SMARCA5 |
miR-432 |
Q
| UP |
More |
| Human |
hsa_circ_SMARCA5 |
- |
Circ‐SMARCA5 |
non-small cell lung carcinoma |
SMARCA5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circSMARCA5 |
breast cancer |
SMARCA5 |
- |
Q
B
H
S
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
circSMARCA5 |
osteosarcoma |
SMARCA5 |
miR-17-3p, miR-432-5p, miR-561-3p, miR-10b-3p, miR-181c-3p, microRNA-432, miR-181c |
Q
| UP |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circSMARCA5 |
childhood ependymoma |
SMARCA5 |
- |
S
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circSMARCA5 |
glioblastoma |
SMARCA5 |
- |
Q
B
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circ SMARCA5 |
cervical cancer |
SMARCA5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
cSMARCA5 |
atherosclerosis |
SMARCA5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
circSMARCA5 |
glioblastoma |
SMARCA5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
circSMARCA5 |
prostate cancer |
SMARCA5 |
miR-181b-5p, miR-17-3p |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circular RNA SMARCA5 |
urinary bladder carcinoma |
SMARCA5 |
miR-432 |
Q
| UP |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
- |
medulloblastoma |
SMARCA5 |
- |
Q
S
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
hsa_circ_00001445 |
colorectal cancer |
SMARCA5 |
miR-181b |
Q
| UP |
More |
| Human |
hsa_circ_SMARCA5 |
- |
- |
prostate cancer |
SMARCA5 |
miR-432 |
Q
| UP |
More |
| Human |
hsa_circ_SMARCA5 |
- |
Circ-SMARCA5 |
colorectal cancer |
SMARCA5 |
miR-93-3p, miR-39-3p, miR-39a-3p |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
circ_0001445 |
hepatocellular carcinoma |
SMARCA5 |
miR-942-5p |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circular RNA SMARCA5 |
non-small cell lung carcinoma |
SMARCA5 |
miR-670-5p |
Q
H
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circSMARCA5 |
malignant colon neoplasm |
SMARCA5 |
miR-552 |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
circ_0001445 |
coronary artery disorder |
SMARCA5 |
miR-208b-5p |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
Circular RNA SMARCA5 |
hepatocellular carcinoma |
SMARCA5 |
- |
Q
| UP |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
- |
laryngeal squamous cell carcinoma |
SMARCA5 |
hsa-miR-432-5p |
Q
M
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circSMARCA5 |
colorectal cancer |
SMARCA5 |
- |
Q
M
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
cSMARCA5 |
hepatocellular carcinoma |
SMARCA5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circSMARCA5 |
urinary bladder carcinoma |
SMARCA5 |
- |
Q
| UP |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
- |
urinary bladder carcinoma |
SMARCA5 |
- |
Q
| UP |
More |
| Human |
hsa_circ_SMARCA5 |
- |
Circular RNA (circRNA) SMARCA5 / circSMARCA5 |
gastric cancer |
SMARCA5 |
miR-346 |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
hsa-SMARCA5_0005 |
preterm premature rupture of the membranes |
SMARCA5 |
- |
S
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
circSMARCA5 / circ1445 |
ovarian cancer |
SMARCA5 |
miR‐576‐5p |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circSMARCA5 |
glioblastoma |
SMARCA5 |
miR-126-3p, miR-515-5p |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circSMARCA5 / circular RNA SMARCA5 |
nasopharyngeal carcinoma |
SMARCA5 |
miR-582-3p |
Q
| UP |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circRNA SMARCA5 / SMARCA5 |
cholangiocarcinoma |
SMARCA5 |
miRNA-95-3p |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circSMARCA5 |
amyotrophic lateral sclerosis |
SMARCA5 |
- |
Q
S
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
hsa_circSMARCA5_013 |
coronary artery disorder |
SMARCA5 |
hsa-miR-507, hsa-miR-375-3p, hsa-miR-576-5p, hsa-miR-942-5p |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
circ-SMARCA5 / circSMARCA5 |
breast cancer |
SMARCA5 |
hsa-mir-375, hsa-mir-942 |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
CircSMARCA5 / circular RNA SMARCA5 |
hepatocellular carcinoma |
SMARCA5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circSMARCA5 |
disease |
SMARCA5 |
- |
Q
S
| UN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circSMARCA5 |
lung adenocarcinoma |
SMARCA5 |
- |
Q
S
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
circSMARCA5 / Circular SMARCA5 |
prostate cancer |
SMARCA5 |
- |
Q
| UP |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
cSMARCA5 |
hepatocellular carcinoma |
SMARCA5 |
miR-17-3p, miR-181b-5p |
Q
S
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
- |
- |
hepatocellular carcinoma |
SMARCA5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
circSMARCA5 |
coronary artery disorder |
SMARCA5 |
- |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
circular RNA SMARCA5 / circSMARCA5 |
cervical cancer |
SMARCA5 |
miR-620 |
Q
| DN |
More |
| Human |
hsa_circ_SMARCA5 |
hsa_circ_0001445 |
cSMARCA5 |
acute myocardial infarction |
SMARCA5 |
- |
Q
| DN |
More |